India's ICMR is launching a stool-based TB test for children. This non-invasive, TRL-5 technology detects drug resistance and targets WHO’s 2030 elimination goals through industry licensing.
The World Health Organization has called on countries to accelerate tuberculosis elimination efforts, unveiling new ...
Abstract: Wearable sensors for biomarker monitoring hold significant potential for chronic health management, particularly in non-invasive, frequent measurement settings such as sweat-based ...
Insight Molecular Diagnostics shares were 23% lower, at $5.72, after the company said it has entered into definitive agreements with certain institutional investors for the purchase and sale of 4.53 ...
The core breakthroughs of the new generation of RNA virus detection technologies focus primarily on two key objectives: first, enhancing biosensor mutation tolerance-specifically, developing sensors ...
New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection. A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by ...
REDWOOD CITY, Calif., Jan. 13, 2026 /PRNewswire/ -- Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building ...
Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one hour has been successfully developed. Compared to conventional testing ...
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $10.9 million in its third quarter. On a per-share basis, the Nashville, ...
Fintel reports that on November 11, 2025, Needham maintained coverage of Insight Molecular Diagnostics (NasdaqCM:IMDX) with a Buy recommendation. As of November 9, 2025, the average one-year price ...
Nov 5 (Reuters) - Molecular diagnostics firm BillionToOne (BLLN.O), opens new tab raised $273.1 million in its U.S. initial public offering on Wednesday, pricing its shares above its marketed range.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results